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INTRODUCTION
Adult T cell leukemia (ATL) has been thought to be
caused by infection of human T cell leukemia virus
(HTLV) type I to T cells (1-2). In patients with ATL,
complication with second primary cancer of the lungs,
vagina, stomach and so on have been reported (3-4), and
occurrence of these clinical cancers are attributed to an
underlying immunodeficiency state of the hosts due to
dysfunction of the helper T cells by the viral infection.
This is the first report of a ATL case complicated with
synchronous primary double cancer of the uterine cervix
and vulva. Leukemic cells of this patient were examined in
detail.
A 70-year-old gravida 4, para 3, Japanese housewife
was referred to the Tokushima University hospital for
further examination of the carcinoma of the vulva. She
complained of vulval itching for 3 years, but there was no
other previous history. Histological examination revealed
the presence of double primary squamous cell carcinomas
of the vulva (clinical stage 0) and the uterine cervix
(stage 1 b). The region located was isolated and the
intraepithelial region was not supposed as a metastasis of
the cervical cancer. There were no skin regions,
lymphadenopathy or hepatosplenomegaly. On admission,
hematological examination revealed leukocytosis up to
383,000/mm 3 with 3.0% polymorphonuclear cells, 1.5%
bands, 0% monocytes and 85.0% abnormal lymphoid cells.
Hemoglobin was 9.0 g/dl and platelet count was 77,000/
mm3. Serum IgG was 1,314 mg/dl, IgM 122 mg/dl, and
IgA 87 mg/dl. Bone marrow aspiration revealed a diffuse
infiltration of lymphoid cells. Surface marker analysis of
the peripheral blood lymphocytes (PBL) was as follows :
OKT3, 32.4% ; OKT4, 94.1% ; OKT6, 0.4% ; OKT8, 7.1% ;
OKT9, 10.3% ; OKT10, 6.9% ; OKT11, 93.5% ; OKTM1, 2.7% ;
Leu7, 1.6% ; B1, 3.3%. Tac antigen was expressed in 31.3%
of peripheral mononuclear cells. Serologic test for
antibody against HTLV associated antigen (ATLA) was
positive at a titer of 1 : 160. From these data, she was
diagnosed as ATL complicated with double primary
cancer.
MATERIALS AND METHODS
Responsiveness to mitogen and interleukin 2 (IL-2)
The mononuclear cells (MNCs) separated by Ficol-Conray
density gradient centrifugation were cultured in a 200 μl
aliquot in a flat bottomed 96-well microtiter plate (A/S
Nunc Kamstrup DK-4000 Roskilde Denmark) with
mitogen or IL-2 in RPMI 1640 (Nissui Pharmaceutical Co.,
Tokyo Jaapan) containing 10% fetal calf serum (FCS)
(GIBCO, Wheaton USA), 2 mM L-glutamine at 37℃ in 5%
CO2 in air. Namely the MNCs were cultured at 1×106
cells/ml with 2 phytohemagglutinin (PHA) (DIFCO
Laboratories, Detroit, MI) and graded concentrations of
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IL-2 (Boehringer Mannheim GmbH, W-Germany) for 24
hours. The cells cultured were pulsed for 4 hours with
0.25 μCi 3H-thymidine, harvested onto paper filters by
Labomash (Labo Science Co., Tokyo, Japan) and the
incorporated radioactivity was determined by a liquid
scintillation counter.
IL-2 production
Ability to produce IL-2 by the leukemic cells was
evaluated according to the method described by Andrew
et al. Peripheral blood mononuclear cells of the patient
were cultured at 4×106 cells /ml in RPMI-1640 containing
5% FCS, 1% PHA and 10 ng/ml PMA (SIGMA, St Louis,
USA) for 48 hours at 37℃ and IL-2 activity in the
supernatant was assessed. Lymphokine activated killer
cells (LAK cells) induced from MNCs from a healthy
donor by culturing for 15 days with 10% IL-2 and IL-2
dependent T cell clone provided by Dr. Hirai (Otsuka
Pharmaceutical Co.) were used as IL-2 dependent cells.
Standard IL-2 were diluted in serial two-fold dilutions with
RPMI-1640 medium. Fifty microtiters of samples and each
dilution was poured into a 96-well microtiter plate in
triplicate. Fifty microliters of the cell suspension at 2×105
cells/ml in RPMI-1640 containing 10% FCS was added to
each well and the mixture was cultured for 18 hours. DNA
synthesis of IL-2 dependent cells was calculated by
incorporation of 3H-thymidine.
Effect on PWM driven lgG synthesis (6)
Peripheral blood mononuclear cells of the patient and
healthy donors were separated into T and non-T fractions
by the nylon wool column methods (7). OKT3+ cells were
more than 97% in the T cell fraction and 21-25% in the
non-T cell fraction, in which the B cell population was
more than 51%. Each fraction of T cells was added at 2×104
and 1×105 cells/well to 1×105 cells/well healthy donor B
cells in 200 μl RPMI-1640 medium containing 10% FCS
in a 96-well microtiter plate. The mixtures were cultured
with 20 μl of 1 : 10 diluted PWM (DIFCO
Laboratories, Detroit, Michigan USA) in
RPMI-1640 medium for 7 days. On day 4,
the medium was totally exchanged with
new medium. IgG production in the cultur
supernatant was measured by a double
antibody sandwich enzyme immunoassay us-
ing immunoplate (Microwell plate, Nunc,
Denmark) coated with goat anti human
lgG (TAGO. Inc. Burlingame CA) at a con-
centration of 50 μg/ml. After adding 100 μl
standard human lgG or samples, the plate
was incubated for 1 hour at 37℃ and washed
3 times with 0.01 M phosphate buffered
saline (PBS) (pH 7.4) containing 0.1% Teeen
20 (PBST). Futher serial incubation with
100 μl of biotinylated goat anti human lgG
antibody (VECTOR Laboratories Inc. Burlin-
game, CA) at 10 μg/ml for 30 min, 100 μl of
horseradish peroxidase avidin D (VECTOR
Laboratories, Inc. CA) at 1 μg/ml for 10 min
and 100 μl of substrate solution (o-phenylene diamine
dihydrochrolide ; 0.4 mg/ml in 0.05 M citrate buffer pH
4.8 containing 0.007% H2O2) per well for 10 min were
carried out at 37℃, and the reaction was stopped with 6
NH2SO4. Absorbance at 490 nm was measured on a SLT
310 ELISA reader (SLT-Labinstrument, Austria). The
samples were assayed in triplicate. The assay range was
from 10 to 500 ng/ml.
RESULTS
Table 1 summarizes the results on responsiveness to
mitogen and IL-2. PBL obtained from the patient did not
respond to PHA or IL-2. On IL-2 assay using LAK cells as
IL-2 dependent cells, no IL-2 activity was detected in the
culture supernatant of patient cells (PC). Furthermore,
the supernatant suppressed the proliferation of LAK cells
in a dose dependent manner (Table 2). No suppression
was detected on the proliferation of PBLs. Similar results
were obtained in the 2 nd experiment using IL-2
dependent cell line (Table 2). Effects of PC and T cell
fraction obtained from a normal healthy donor on
PWM-driven lgG production are shown in Fig 1. T cell
fraction of the healthy donor showed helper activity, while
PC suppressed lgG production. Cytotoxic effect of the
supernatant was excluded by trypan blue dye exclusion
test (data not shown) and an absence of the suppressing
effect on the proliferation of normal lymphocytes (Table
2).
DISCUSSION
The diagnosis of ATL for the present patient was based
on the findings of positive serologic test for ATLA and
characteristic cell surface marker phenotype of PBL (8),
OKT1+3+4+8- and Tac+ (9), though direct evidence of the
infection of HTLV to leukemic cells was not obtained. She
seemed to have suffered from smouldering type of
ATL for a long time, because only a few leukemic cells
showed abnormal shaped nuclei and no clinical findings
Table 1. Responsiveness of peripheral blood mononuclear cells (PBL) to PHA
and IL-2
1) All cultures were carried out in RPMI-1640 medium containing 10%
FCS and 2 mM L-glutamine
2) 3H-thymidine uptake (count per minutes, mean±standard deviation)
PHA : Phytohemagglutinin
IL-2 : interleukin 2
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that are often found in patients with ATL such as
cutaneous lesions, hepatosplenomegaly, Iymphadenopathy
or hypercalcemia, which are thought to be due to
infiltration of malignant cells (10). Immunological investi-
gation revealed the dysfunction of the lymphoid cells in
the patient. The leukemic cells did not respond to PHA
(11) or IL-2, although 31.3% of the cells had Tac+
phenotype, which is known to be the site of IL-2 receptor.
The leukemic cells had a phenotype of helper T cell,
OKT3+4+ and OKT8-, but the function was more like
suppressor T cells than helper T cells. Similar results
were reported previously by several investigators (12-13).
Furthermore, in the IL-2 production assay, supernatant of
the leukemic cells cultured with or without both PHA and
PMA, suppressed dose-dependently the incorporation of
3H-thymidine by IL-2 dependent cells than the control.
And in the response to IL-2, IL-2 inhibited the proliferation
of tumor cells dose-dependently. These find-
ings suggest that IL-2 promoted the inhibitory
effect of a factor produced by tumor cells. One
possibility is that this factor inhibited the
proliferation via IL-2 receptor (IL-2 R). And
IL-2 upregulated the IL-2 R expression resulting
in the promotion of the inhibitory effect of the
factor. Burton et al. (14) reported that in the
late phase of ATL, leukemic cells no longer
produced IL-2. Tatsumi et al. (15) reported
leukemic cells from ATL suppressed the
proliferative response of normal T cells to
alloantigens. Mori, et al. (16) also reported the
culture supernatant from ATL suppressed
lymphocyte proliferative responses to stimu-
lation with mitogens. Honda et al. (17), Hardt
et al. (18) and Lelchuk et al. (19) reported that
IL-2 inhibitor produced in the supernatant of
MLR in rodents blocked production of IL-2
from helper T cells and expression of the
activities. Furthermore, production of IL-2
inhibitor by cancer cells was reported by
Fontana et al. (20). Since these IL-2 inhibitors have not
been fully characterized, it is not clear whether IL-2
inhibitor like factor in this patient was same as the factors
reported previously. However as cells in ATL are
transformed from OKT4+ cells, the factors inhibiting IL-2
dependent cell lines may be similar to suppressor factors
produced by OKT4+ suppressor T cells or abnormal IL-2
by OKT4+ helper T cells. The effect of contaminated
normal lymphocytes is supposed low, and same
conclusion is obtained if the contaminated normal
lymphocytes had functioned to some extent. Thus, the
leukemic cells induced an immunodeficiency state in the
host resulting in the occurrence of multiple primary
cancers. The incidence of synchronous double carcinoma
of the vulva and uterine cervix is very low. We
experienced only one case in a total of 1156 patients with
gynecologic carcinomas in the last of 13 years in our
clinics. In fact, high occurence of primary malignant
neoplasms have been reported in patients with ATL (21),
especially smouldering type (5/18 cases (28%)) (4). ATL
is a profoundly immunosuppressive malignancy (22).
In patients with other leukemia, the incidence of
synchronous primary malignancies is not rare, but not
frequent. Mansow, et al. (23) reported that the risk of all
cancers developing in patients with CLL is threefold that
for the age- and sex-matched population. In another report
(24), from 2134 patients with leukemia, synchronous
primary lesions was diagnosed in 27 cases (1.3%). Human
immunodeficiency virus (HIV) was known as another
human T-Iymphotropic virus (HTLV). In AIDS patients,
Kaposi's sarcoma, opportunistic infection and malignant
lymphoma are commnon causes of complications and
mortality. The immunodefficient state in AIDS patients is
accounted for by the depletion of T 4+ cells. Whereas
humoral factor in the culture supernatant of HIV-infected
cells which inhibits PWM-driven lgG synthesis, and T-cell
proliferation responding to Tetanus Toxoid was reported
Table 2. Effect of culture supernatant of the leukemic cells on proliferation of IL-２
dependent cells
Exp.1 culture supernatant of PBL not stimulated
Exp.2 culture supernatant of PBL stimulated with PHA and PMA. All cultures were
carried out in RPMI-1640 medium containing 10%. FCS and 2 mM (L-glutamine*
3H-thymidine uptake (count per minutes , mean±standard deviation)
IL-2 : Interleukin-2
LAK : Iymphokine activated killer cells
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by Laurence, et al. (25). Thus, the onset of double
carcinoma found in this patient seems to be based on the
immunodeficient state caused by the leukemic cells. To
my knowledge, this is the first report of an ATL patient
complicated with double cancer of the uterine cervix and
vulva.
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